# xma-lab.github.io
Ma Lab website - Cancer immunotherapy research at UAB
# Ma Lab - Cancer Immunotherapy Research
**University of Alabama at Birmingham | Department of Genetics**

## About

The Ma Lab investigates the fundamental mechanisms of immune surveillance in cancer, focusing on how DNA damage responses and epigenetic dysregulation influence immunotherapy outcomes. Led by Dr. Xiaoxiao Ma, our research aims to develop next-generation cancer treatments through mechanistic insights into tumor immunity.

## Research Focus

ğŸ§¬ **DNA Damage, epigenetic dysregulation & Tumor immunology** - How mutagenesis and repair defects and epigenetic disruption impact immune recognition and drive immunotherapy resistance
ğŸ¯ **Cancer Vaccine and TCR-therapy development** - Advanced pipelines for TCR identification and immunogenicity prediction  
âš—ï¸ **Synthetic biology approach to improve antigen presentation** - Expand the targetability of non-canonical antigens

## Key Publications

- **Nature Genetics** (2022): Functional Landscapes of POLE and POLD1 Mutations in Checkpoint Blockade-Dependent Anti-Tumor Immunity.
- **Nature Cancer** (2020): Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy. 
- **Trends in Cancer** (2022): Solving the puzzle of what makes immunotherapies work. 

## Opportunities

We welcome **rotation students** and **postdoctoral fellows** interested in:
- Cancer immunotherapy mechanisms
- Computational immunogenomics
- DNA damage repair pathways
- Translational tumor immunology research

## Contact

**Dr. Xiaoxiao Ma**  
ğŸ“§ maxx@uab.edu  
ğŸ“ 205-934-5948  
ğŸ¢ Department of Genetics, UAB School of Medicine

---

**Website**: [View Lab Website](https://[your-username].github.io/xiaoxiao-ma-lab)  
**Publications**: [PubMed Profile](https://www.ncbi.nlm.nih.gov/myncbi/xiaoxiao.ma.1/bibliography/public/)
